Novartis to acquire majority control of eye-care major Alcon

Novartis intends to gain full ownership of Alcon Inc by first completing the April 2008 agreement with Nestlé SA to acquire a 77 per cent majority stake in a global leader in eye care and subsequently entering into an all-share direct merger with Alcon for the remaining 23 per cent minority stake.

The details can be read here.